For the Inventor, By the Inventor

Enter assignee name

Aventis Pasteur S.a.

USPTO Granted Patents = 17

Forward Citations = 178

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Michel Chevalier (6 out of 9 patents)

Jean Haensler (3 out of 13 patents)

Monique Moreau (3 out of 10 patents)

4. Tino Krell (3 out of 3 patents)

5. Alain Françon (2 out of 8 patents)

6. Jorge Ronco (2 out of 2 patents)

7. Philippe Talaga (1 out of 9 patents)

8. Noëlle Mistretta (1 out of 8 patents)

9. Raphaëlle Claude El Habib (1 out of 2 patents)

10. Régis Sodoyer (1 out of 4 patents)

11. Catherine Moste (1 out of 4 patents)

12. Emilie Danve (1 out of 1 patent)

13. Robert Brasseur (1 out of 6 patents)

14. Patricia Sepulcri (1 out of 1 patent)

15. Sandrine Vialle-Blanc (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 7812006 - Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide (2010-10-12),

2. 7767658 - Vaccine composition (2010-08-03),

3. 7404960 - Multivalent vaccine composition having increased stability of capsular polysaccharide (2008-07-29),

4. 7320874 - [object Object] (2008-01-22),

5. 7122094 - Method and apparatus for sterile connection between two flexible tubes (2006-10-17),

6. 7056519 - Methods for inducing HIV-neutralizing antibodies (2006-06-06),

7. 6982088 - Vaccine composition and stabilization method using high molecular weight PVP (2006-01-03),

8. 6861253 - Polypeptide inducing antibodies neutralizing HIV (2005-03-01),

9. 6821723 - GP41 antigen (2004-11-23),

10. 6780421 - Adjuvant for a vaccine composition (2004-08-24),

11. 6737067 - Trimer of HIV env gene expression product (2004-05-18),

12. 6664049 - Method and device for cell lysis (2003-12-16),

13. 6641816 - Use of poxviruses as enhancer of specific immunity (2003-11-04),

14. 6610308 - Immunostimulant emulsion (2003-08-26),

15. 6596861 - Method for the reductive amination of polysaccharides (2003-07-22),

Aventis Pasteur S.A. is a leading global biopharmaceutical company that specializes in the research, development, and production of vaccines. With a mission to prevent and treat diseases, Aventis Pasteur aims to protect people's health and well-being worldwide. Their innovative vaccines target a range of infectious diseases, including influenza, meningitis, polio, hepatitis, and more. Visit their website to learn more about their groundbreaking work and contributions to public health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

17 Patents

#6 in Lyon

#1,129 in France

#34,814 in the World

Aventis Pasteur S.a.

Forward Citations = 178

31 inventors:

Michel Chevalier (6 out of 9 patents)

Jean Haensler (3 out of 13 patents)

Monique Moreau (3 out of 10 patents)

4. Tino Krell (3 out of 3 patents)

5. Alain Françon (2 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…